Effects of nutritional lipids on diabetic manifestations and Δ6 desaturase mRNA level in streptozotocin treated mice

Nutrition Research

Volumn 24, Issue 4, 2004, Pages 303-312

  Frenkel, Alicia Leikin ^a   Canetti, Lea ^a   Halpern, Zamir ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

6 desaturase; Fatty acids; Liver; Mice; Nutritional lipids; Type 1 diabetes

Indexed keywords

FATTY ACID; INSULIN; LIPID; MESSENGER RNA; PALMITIC ACID; PROSTAGLANDIN; SOYBEAN OIL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FAT INTAKE; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; INSULIN METABOLISM; MALE; MOUSE; NONHUMAN; NUTRITION; PANCREAS INJURY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALIA; GLYCINE MAX;

EID: 1642372275     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2003.11.006     Document Type: Article

References (31)

1. Brenner R.R. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res. 20:1981;41-47.
2. Mercuri O., Peluffo R.O., Brenner R.R. Depression of microsomal desaturation of linoleic acid to γ-linolenic acid in the alloxan-diabetic rat. Biochim Biophys Acta. 116:1966;409-411.
3. Mercuri O., Peluffo R.O., Brenner R.R. Effect of insulin on the oxidative desaturation of α-linolenic, oleic and palmitic acids. Lipids. 2:1967;284-285.
4. Horrobin D. Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes 1997;46(suppl 2):S90-3.
5. Horrobin D. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res. 31:1992;163-194.
6. Horrobin D. Omega-6 essential fatty acids. In: Pathophysiology and roles in clinical medicine. New York: Wiley-Liss, Horrobin, D., Ed. 1990. p. 573.
7. German J.B., Dillard C., Whelan J. Biological effects of dietary arachidonoc acid introduction. J Nutr. 126:(4 suppl):1996;1076S-1180S.
8. Jamal G.A. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabet Med. 11:1994;145-149.
9. Brenner R., Peluffo R., Mercuri O., Restelli M. Effect of arachidonic acid in the alloxan-diabetic mouse. Am J Physiol. 215:1968;63-70.
10. Chavali S.R., Forse R.A. Decreased production of interleukin-6 and prostaglandin E2 associated with inhibition of delta;-5 desaturation of omega-6 fatty acids in mice fed safflower oil diets supplemented with sesamol. Prostaglandins Leukot Essent Fatty Acids. 61:1999;347-352.
11. Mason T., Goh T., Tchipashvili V., Sandhu H., Gupta N., Lewis G., Giacca A. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes. 48:1999;524-530.
12. Boden G. Free fatty acids, insulin resistance and type 2 diabetes mellitus. Proc Assoc Am Physicians. 111:1999;241-248.
13. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46(1):63-410.
14. Poisson J.P. Essential fatty acid metabolism in diabetes. Nutrition. 5:1989;263-266.
15. Brenner R.R., Peluffo R.O. Effect of saturated and unsaturated fatty acids on the desaturation in vitro of palmitic, stearic, oleic linoleic and linolenic acid. J Biol Chem. 241:1966;5213-5219.
16. Meydani S.N., Lichtenstein A., White P., Goodnigh S., Elson C., Woods M., Gorbach S., Schaefer E. Food use and health effects of soybean and sunflower oils. J Am Coll Nutr. 10:1991;406-428.
17. Cho H., Nakamura M., Clarke S. Cloning, expression and nutritional regulation of mammalian delta 6 desaturase. J Biol Chem. 274:1999;471-477.
18. Clarke S, Jump D. Polyunsaturated fatty acid regulation of hepatic gene transcription. Lipids 1996;31Suppl:S7-11.
19. Kanki H., Fukuda K., Okushi K., Ibata I., Toyama Y., Shimizu H., Arakawa Y., Ogawa S. Comparison of nerve growth factor mRNA expression in cardiac and skeletal muscle in streptozotocin induced diabetic mice. Life Sci. 65:1999;2305-2313.
20. Folch J.M., Lees M., Sloane-Stanley J.A. Simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1957;497-499.
21. Leikin A.I., Brenner R.R. In vivo phospholipid modification induces changes in microsomal Δ5 desaturase activity. Biochem Biophys Acta. 1165:1992;189-193.
22. Honjo K., Doi K., Mitsuoka T. Histopathology of streptozotocin-induced diabetic DBA/2N and CD-1 mice. Lab Anim. 20:1986;293-296.
23. Shimabukuro M., Yan-Tin Z., Levi M., Unger R. Fatty acid-induced β cell apoptosis a link between obesity and diabetes. Proc Natl Acad Sci, USA. 95:1998;2492-2498.
24. Warnotte C., Gilon P., Memquin M., Henquin J.P. Mechanisms of the stimulation of insulin release by saturated fatty acids. Diabetes. 43:1994;703-711.
25. Thams P., Kapito K. Differential mechanisms of glucose and palmitate in augmentation of insulin secretion in mouse pancreatic islets. Diabetologia. 44:2002;738-746.
26. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 50:2001;537-546.
27. Krishna I., Mohan U., Das N. Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition. 17:2001;126-151.
28. Rimoldi O., Finarelli G., Brenner R.R. Effects of diabetes and insulin on hepatic Delta6 desaturase gene expression. Biochim Biophys Res Commun. 283:2001;323-326.
29. Gasperkov D., Demckov E., Ukropec J., Klimes I., Sebkov E. Insulin resistance in the hereditary hypertriglyceridemic rat is associated with an impairment of Δ6 desaturase expression in liver. Ann NY Acad Sci. 967:2002;446-453.
30. Spector AA. Essentiality of fatty acids. Lipids 199934(suppl S1-S3).
31. Burr G.O., Burr M.M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem. 82:1926;342-367.